ArticleOncology letters2021

PRMT1 expression predicts response to neoadjuvant chemotherapy for locally advanced uterine cervical cancer.

Masahiro Shimomura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.